PIK3CA and breast cancer: The PIK3CA mutation exhibited unfavorable prognostic significance in patients with both overall and triple-negative BCs, indicating the potential of PIK3CA mutation with c-Met or MSI/MMR as a detailed prognostic marker in BC subsets, especially in Asian women.